BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA maintains buy on Dr. Lal Pathlabs
Dr. Lal Pathlabs is well positioned to capture the business shift towards organised diagnostic players. Strong franchise network is the key to success. Expansion of reference lab in Kolkata is on track. Rising volumes to be the key lever for growth of the company.